These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3956341)

  • 1. Esophagus and toxic oil syndrome.
    Abaitua Borda I; Posada de la Paz M; Diaz de Rojas F; Castro Garcia M; Tabuenca Oliver JM; Alonso Gordo JM
    Dig Dis Sci; 1986 Apr; 31(4):443. PubMed ID: 3956341
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercoagulable states and the toxic oil syndrome.
    Castro García M; Posada M; Diaz de Rojas F; Abaitua Borda I; Tabuenca Oliver JM
    Ann Intern Med; 1986 May; 104(5):730. PubMed ID: 3963676
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary hypertension after toxic rapeseed oil ingestion.
    Castro García M; Posada de la Paz M; Díaz de Rojas F; Abaitua Borda I; Alonso Gordo JM; Tabuenca Oliver JM
    J Am Coll Cardiol; 1984 Aug; 4(2):443. PubMed ID: 6549605
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of fatty acid anilides in rabbits and the pathogenesis of the Spanish toxic oil syndrome.
    Marquet A; Larraga V; Diez JL; Amela C; Rodrigo J; Muñoz E; Pestaña A
    Experientia; 1984 Sep; 40(9):977-80. PubMed ID: 6205897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital tuft alterations in toxic oil syndrome.
    Alonzo-Ruiz A; Zea-Mendoza AC; González-Lanza M; Gómez-Catalán E
    Lancet; 1984 Sep; 2(8401):520-1. PubMed ID: 6147578
    [No Abstract]   [Full Text] [Related]  

  • 6. 3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?
    Philen RM; Hill RH
    Mayo Clin Proc; 1993 Feb; 68(2):197-200. PubMed ID: 8423703
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxic oil syndrome, Spain: effect of oleoylanilide on the release of polysaturated fatty acids and lipid peroxidation in rats.
    Suarez A; Viloria MD; Garcia-Barreno P; Municio AM
    Arch Environ Contam Toxicol; 1985 Mar; 14(2):131-6. PubMed ID: 3920977
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of the alimentary toxic oil syndrome due to ingestion of denatured rapeseed oil.
    Gilsanz V; Alvarez JL; Serrano S; Simón J
    Arch Intern Med; 1984 Feb; 144(2):254-6. PubMed ID: 6696559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of the toxic oil syndrome.
    Philen RM; Posada de la Paz M; Hill RH; Schurz HH; Abaitua Borda I; Gómez de la Cámara A; Kilbourne EM
    Arch Toxicol Suppl; 1997; 19():41-52. PubMed ID: 9079193
    [No Abstract]   [Full Text] [Related]  

  • 10. Analytical measurements of products of aniline and triglycerides in oil samples associated with the toxic oil syndrome.
    Schurz HH; Hill RH; Philen RM; Posada de la Paz M; Abaitua Borda I; Kilbourne EM; Bernert T; Needham LL
    Arch Toxicol Suppl; 1997; 19():53-64. PubMed ID: 9079194
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
    Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia and toxic oil syndrome in Spain.
    Såenz A; Rojas-Hidalgo E; Cordon E; Izquierdo M; del Valle MG
    Diabetes Care; 1991 May; 14(5):424. PubMed ID: 2060456
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicologists versus toxicological disasters: toxic oil syndrome, clinical aspects.
    Gómez de la Cámara A; Abaitua Borda I; Posada de la Paz M
    Arch Toxicol Suppl; 1997; 19():31-40. PubMed ID: 9079192
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral repercussions in the toxic syndrome caused by adulterated rapeseed oil].
    Carrion Lacalle F; Calatrava Paramo L
    Rev Esp Estomatol; 1982; 30(1):21-8. PubMed ID: 6953533
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological aspects of the toxic oil syndrome.
    Lahoz C; del Pozo V; Gallardo S; Cárdaba B; Jurado A; Cortegano I; del Amo A; Arrieta I; Palomino P
    Arch Toxicol Suppl; 1997; 19():65-73. PubMed ID: 9079195
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
    Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM
    Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic oil syndrome.
    Beranek JT
    Am Heart J; 1991 Dec; 122(6):1792-3. PubMed ID: 1957784
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxic oil syndrome.
    Spurzem JR; Lockey JE
    Arch Intern Med; 1984 Feb; 144(2):249-50. PubMed ID: 6696556
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic oil syndrome.
    Fitzpatrick KC
    Am Heart J; 1992 Jun; 123(6):1722-3. PubMed ID: 1595563
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous mucinosis in the toxic oil syndrome.
    Fonseca E; Contreras F
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):139-40. PubMed ID: 3805384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.